يحاول ذهب - حر
Taking Science Into Their Own Hands
August 01 - 08, 2025 (Double Issue)
|Newsweek US
In the race to treat rare disease, families are leading the charge to find cures themselves
WHEN CASEY MCPHERSON became a father, his purpose became clear. He needed to raise his daughter, Rose, to be loving, courageous, healthy and strong. He needed to protect her.
So when the pediatric neurologist told McPherson that Rose had a rare genetic disease—so uncommon that it didn’t even have a name—parental instinct kicked in. And when the doctor said: “There’s nothing we can do,” that instinct sharpened.
“Rose was being attacked, but there wasn’t a monster for me to kill or a car for me to throw myself in front of,” McPherson told Newsweek. “It was just one little nucleotide in the gene. And if that’s the monster for me to kill, then that’s the monster I’m going after.”
Rose, now 9, and McPherson, 46, fight against that “monster” disease in little ways each day. Their home in a suburb of Austin, Texas, is “Rosie-proofed,” as McPherson said. She sleeps in a special bed equipped with barriers to keep her from wandering off, and a video camera plus oxygen and pulse monitors scan for signs of seizures in the night. Rose doesn’t have the restraint of a neurotypical 9-year-old, so chemicals and electronics are kept behind three levels of locks. She takes seizure medication twice a day, and goes to a private school for children with special needs (paid for out of pocket, because there was a 15-year waiting list for any sort of financial assistance).
Before, McPherson was known as the frontman of the alternative rock bands Alpha Rev and Flying Colors. After Rose’s diagnosis in 2016, he took on a new role as a founder, launching the nonprofit To Cure a Rose Foundation, the contract research organization Everlum Bio and now the public benefit corporation AlphaRose Therapeutics. All three seek to find and fund cures for children with exceedingly rare genetic diseases, like Rose’s.
McPherson is among a rising number of parents, spouses and patients seeking cures for rare diseases. Many of them are not scientists or doctors.
هذه القصة من طبعة August 01 - 08, 2025 (Double Issue) من Newsweek US.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Newsweek US
Newsweek US
The Missing Bombers of Trump 2.0
President Donald Trump's second term is easy to read if you focus only on the visible damage: tariffs, agency purges, courtroom fights, public threats.
1 mins
May 08-15, 2026
Newsweek US
'CALIFORNIA IS DESPERATE FOR CHANGE'
Steve Hilton is looking to become the first Republican elected governor in the Golden State since Arnold Schwarzenegger. Can his focus on housing, homelessness and the cost of living guide him to victory in November?
5 mins
May 08-15, 2026
Newsweek US
RICHARD GADD
The actor follows Baby Reindeer with Half Man, an HBO limited series about two repressed “brothers” in Glasgow. “I came up with the two characters, and I couldn't shake them.”
2 mins
May 08-15, 2026
Newsweek US
Q&A STEVE HILTON
It's politics.
2 mins
May 08-15, 2026
Newsweek US
THE MIDDLE EAST THAT BENJAMIN NETANYAHU BUILT
How the vision of Israel's longest-serving premier came to reality—that strength, not agreement, delivers security
10 mins
May 08-15, 2026
Newsweek US
INTO THE LION'S DEN
Charles III's visit to the United States came as the nation is at loggerheads with the U.K. over the war in Iran. Can the king rescue the special relationship?
7 mins
May 08-15, 2026
Newsweek US
CUTTING THROUGH THE CHAOS
It’s business as usual for Mohammad Mehdi as he cuts Ayman Al Zein’s hair on April 18—despite being surrounded by rubble after his barber shop, in Beirut’s Dahiyeh suburb, was damaged in an Israeli strike.
1 min
May 08-15, 2026
Newsweek US
One Personal Download, One Corporate Nightmare
When Vercel-a cloud platform used by businesses worldwide confirmed in April that customer credentials and internal data had been compromised, the attack that caused it required no sophisticated malware, zerodays or insider access.
1 min
May 08-15, 2026
Newsweek US
Live Nation Lost. But Who Won?
At the height of Pearl Jam's success in 1994—and nearly eight months after the rock band filed an antitrust complaint against Ticketmaster—Rolling Stone asked, \"If Pearl Jam couldn't do it, who can?\" Well, 31 years later, it turns out the Swifties can. Kind of.
1 min
May 08-15, 2026
Newsweek US
THE BENEFITS OF A GUIDING HAND
Well-designed Al governance does not suppress innovation—it shapes its direction in socially beneficial ways
4 mins
May 08-15, 2026
Listen
Translate
Change font size
